Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2018-05-01
2019-05-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of GOS Supplementation on Amoxicillin-treated Gut Microbiota From Healthy Adults
NCT01848535
Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults
NCT06068894
Inulin and the Gut Microbiota in Healthy Adults
NCT05399316
Pilot Study on the Effect of a XOS95 on the Human Gut Microbiome
NCT03074019
Multiomic Signatures of Microbial Metabolites Following Prebiotic Fiber Supplementation
NCT03925597
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prebiotic A
Prebiotic A - inulin
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic B - galactooligosaccharides(GOS)
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic C - wheat dextrin
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic B
Prebiotic A - inulin
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic B - galactooligosaccharides(GOS)
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic C - wheat dextrin
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic C
Prebiotic A - inulin
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic B - galactooligosaccharides(GOS)
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic C - wheat dextrin
Pre-weighed packages will be given twice daily for 5 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prebiotic A - inulin
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic B - galactooligosaccharides(GOS)
Pre-weighed packages will be given twice daily for 5 days.
Prebiotic C - wheat dextrin
Pre-weighed packages will be given twice daily for 5 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* No known allergy to milk products or lactose intolerance
* no known allergy to wheat or gluten intolerance
* no history of irritable bowel syndrome
* no history of inflammatory bowel disease
* no history of type-2 diabetes
* no history of chronic kidney disease or reduced kidney function
* no current intestinal obstructions
* no current untreated colorectal cancer
* not currently pregnant or breastfeeding
17 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lawrence David
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00087214
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.